<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        22-584-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NAUSIDOM 10 mg Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DOMPERIDONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        11.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="NEOPHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            NEOPHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NEOPHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A03FA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of your medicine is Nausidom 10 mg Film-Coated Tablets. Nausidom<br />contains a medicine called domperidone. This belongs to a group of medicines<br />called &lsquo;dopamine antagonists&rsquo;.<br />Nausidom works by helping to move food faster through your food pipe<br />(oesophagus), stomach and gut. This is so that it does not stay in the same<br />place for too long. It also helps stop food flowing the wrong way back up your<br />food pipe.<br />Nausidom can be used for the following:<br />Adults<br />&bull; To stop or prevent you feeling sick (nausea) or being sick (vomiting)<br />&bull; To stop or prevent the feeling of fullness during or shortly after a meal<br />&bull; To treat stomach discomfort, or heartburn caused by the flow of the<br />stomach contents back into your food pipe<br />Children<br />&bull; To stop or prevent children feeling sick (nausea) or being sick (vomiting)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NAUSIDOM<br />Do not take Nausidom tablets if:<br />&bull; You are allergic (hypersensitive) to domperidone or any of the other<br />ingredients of Nausidom 10 mg Film-Coated Tablets (listed in section<br />6: Contents of the pack and other information). Signs of an allergic<br />reaction include: a rash, swallowing or breathing problems, swelling of<br />your lips, face, throat or tongue.<br />&bull; You have a tumour of the pituitary gland (prolactinoma)<br />&bull; You have a blockage or tear in your intestines<br />&bull; You have black, tarry bowel motions (stools) or notice blood in your bowel<br />motions. This could be a sign of bleeding in the stomach or intestines.<br />&bull; If you have or have had liver problems.<br />Do not take Nausidom if any of the above applies to you. If you are not sure, talk<br />to your doctor or pharmacist before taking Nausidom.<br />Take special care with Nausidom and check with your doctor or<br />pharmacist before taking this medicine if:<br />&bull; You have any kidney problems. If you take Nausidom over a long period,<br />your doctor may want to lower the amount you use. This will depend on<br />how severe your kidney problems are<br />If you are not sure if any of the above apply to you, talk to your doctor or<br />pharmacist before taking Nausidom. Do this even if they have applied in the<br />past.<br />Nausidom may be associated with an increased risk of heart rhythm disorder<br />and cardiac arrest. This risk may be more likely in those over 60 years old or<br />taking doses higher than 30 mg per day. Nausidom should be used at the<br />lowest effective dose in adults and children.<br />Other medicines and Nausidom<br />Please tell your doctor or pharmacist if you are taking or have recently taken<br />any other medicines. This includes medicines you can buy without a<br />prescription, including herbal medicines. This is because Nausidom can affect<br />the way some other medicines work. Also, some medicines can affect the way<br />Nausidom works.<br />Do not use Nausidom and tell your doctor if you are taking any of the following:<br />&bull; Ketoconazole tablets or liquid for fungal infections<br />&bull; Antibiotics for infections (such as erythromycin)<br />Taking Nausidom with food and drink<br />It is recommended to take Nausidom before meals, as when taken after meals<br />the absorption of the medicine is slightly delayed.<br />Pregnancy and breast-feeding<br />Talk to your doctor or pharmacist before taking Nausidom if:<br />&bull; You are pregnant, might become pregnant or think you may be pregnant<br />&bull; You are breast-feeding. It is best not to take Nausidom if you are<br />breast-feeding. This is because small amounts may pass into the mother&rsquo;s<br />milk<br />Driving and using machines:<br />Nausidom does not affect your ability to drive or use machines.<br />Important information about some of the ingredients of Nausidom tablets<br />This medicine contains lactose. If you have been told that you cannot digest or<br />tolerate some sugars, talk to your doctor before taking Nausidom.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Nausidom tablets exactly as your doctor has told you. You should<br />check with your doctor or pharmacist if you are not sure.<br />Taking this medicine<br />&bull; Swallow the tablets whole with a drink of water.<br />&bull; Take the tablets 15 to 30 minutes before a meal and, if needed, before<br />you go to bed.<br />&bull; Do not crush or chew them.<br />The usual dose is:<br />&bull; Adults and teenagers (over 12 years and who weigh more than 35 kg)<br />Take one or two Nausidom tablets (10 or 20mg) 3 to 4 times a day.<br />Do not take more than 8 tablets (80 mg) in a day.<br />&bull; Use in children<br />Do not give Nausidom tablets to children under 12 years of age and<br />weighing less than 35kg.<br />People with kidney problems<br />Your doctor may tell you to take a lower dose or to take the medicine less often.<br />How long can I take this medicine for?<br />Your doctor will decide how long you will need to take this medicine.<br />If you take Nausidom tablets for more than 2 weeks your doctor may wish to see<br />you again. This is to check if you need to keep taking the treatment.<br />If you take more Nausidom than you should:<br />&bull; If you have taken more Nausidom tablets than you should, talk to a doctor<br />or go to the nearest hospital casualty department straight away. Take the<br />carton and any tablets left with you. This is so the doctors know what you<br />have taken.<br />&bull; The signs of taking more than you should include feeling sleepy, confused,<br />uncontrolled movements (especially in children) which include unusual eye<br />movements, unusual movements of the tongue or abnormal posture (such<br />as a twisted neck).&nbsp;If you forget to take Nausidom:<br />&bull; If you forget to take Nausidom, take it as soon as you remember.<br />&bull; However if it is time for the next dose, skip the missed dose.<br />&bull; Do not take a double dose to make up for a forgotten dose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>4. POSSIBLE SIDE EFFECTS<br />Like all medicines, Nausidom can have side effects, although not everybody<br />gets them.<br />Stop taking Nausidom and see your doctor or go to a hospital straightaway if:<br />&bull; You get swelling of the hands, feet, ankles, face, lips or throat which may<br />cause difficulty in swallowing or breathing. You could also notice an itchy,<br />lumpy rash (hives) or nettle rash (urticaria). This may mean you are having<br />an allergic reaction to Nausidom.<br />&bull; You notice any uncontrolled movements. These include irregular eye<br />movements, unusual movements of the tongue, and abnormal posture such<br />as a twisted neck, trembling and muscle stiffness. This is more likely to<br />happen in children. These symptoms should stop once you stop taking<br />Nausidom.<br />&bull; You have a very fast or unusual heartbeat. This could be a sign of a<br />life-threatening heart problem.<br />&bull; You have a fit (seizure).<br />Other side effects include:<br />Common (affects less than 1 in 10 people)<br />&bull; Dry mouth<br />Uncommon (affects less than 1 in 100 people)<br />&bull; Lowering of sexual drive (libido) in men<br />&bull; Feeling anxious<br />&bull; Feeling drowsy<br />&bull; Headaches<br />&bull; Diarrhoea<br />&bull; Itchy skin. You may also have a rash<br />&bull; Unusual production of breast milk in men and women<br />&bull; Painful or tender breasts<br />&bull; A general feeling of weakness<br />Frequency cannot be estimated from the available data<br />&bull; Feeling agitated or irritable<br />&bull; Feeling more nervous than usual<br />&bull; Abnormal eye movements<br />&bull; Inability to urinate<br />&bull; Breast enlargement in men<br />&bull; In women, menstrual periods may be irregular or stop<br />&bull; A blood test shows changes in the way your liver is working.<br />Some patients who have used Nausidom for conditions and dosages requiring<br />longer term medical supervision have experienced the following unwanted<br />effects:<br />Restlessness; swollen or enlarged breasts, unusual discharge from breasts,<br />irregular menstrual periods in women, difficulty breastfeeding, depression,<br />hypersensitivity.<br />Nausidom may be associated with an increased risk of heart rhythm disorder<br />and cardiac arrest. This risk may be more likely in those over 60 years old or<br />taking doses higher than 30 mg per day. Nausidom should be used at the<br />lowest effective dose in adults and children.<br />Side effects such as feeling drowsy, nervous, agitated or irritable or having a fit<br />are more likely to happen in children.<br />Talk to your doctor or pharmacist if any of the side effects gets serious or lasts<br />longer than a few days, or if you notice any side effects not listed in this leaflet.<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>5. HOW TO STORE NAUSIDOM<br />&bull; Keep out of the sight and reach of children.<br />&bull; Store below 30&deg;C.<br />&bull; Do not take Nausidom Tablets after the expiry date stated on the pack.<br />&bull; Ask your pharmacist how to dispose of medicines you no longer need.<br />Do not dispose of medicines by flushing down a toilet or sink, or by<br />throwing them out with your normal household rubbish. This will help<br />to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Nausidom 10 mg Film-Coated Tablets contain<br />Each Nausidom Tablet contains 10 mg of Domperidone (the active ingredient).<br />It also contains Lactose, Maize Starch, Sodium Lauryl Sulphate, Microcrystalline<br />Cellulose, Povidone, Magnesium Stearate, Colloidal Anhydrous Silica,<br />Opadry White Y-1-7000 and Purified Water.<br />What Nausidom 10 mg Film-Coated Tablets look like and contents of the<br />pack<br />Each pack contains 30 (3 x 10&rsquo;s) white to off-white coloured circular shaped,<br />film-coated tablets having &lsquo;n&rsquo; debossed on one side and &lsquo;10&rsquo; debossed on the<br />other side.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Nausidom 10 mg Film-Coated Tablets contain
Each Nausidom Tablet contains 10 mg of Domperidone (the active ingredient).
It also contains Lactose, Maize Starch, Sodium Lauryl Sulphate, Microcrystalline
Cellulose, Povidone, Magnesium Stearate, Colloidal Anhydrous Silica,
Opadry White Y-1-7000 and Purified Water.
What Nausidom 10 mg Film-Coated Tablets look like and contents of the
pack
Each pack contains 30 (3 x 10’s) white to off-white coloured circular shaped,
film-coated tablets having ‘n’ debossed on one side and ‘10’ debossed on the
other sid
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Neopharma</p><p>Plot A-1 89-95, ICAD, Mussafah,<br />P.O. Box 72900, Abu Dhabi, UAE.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>١. ما هو نوسيدوم ولماذا يستعمل<br />اسم هذا الدواء هو أقراص نوسيدوم المغلفة. يحتوي نوسيدوم على المادة الفعالة<br />دومبيريدون. يندرج هذا الدواء ضمن مجموعة الأدوية التي تسمى &rdquo;مضادات الدوبامين&ldquo;.<br />يعمل النوسيدوم على المساعدة لتحريك الطعام بصورة أسرع خلال مجرى الطعام<br />(المريء)، المعدة والأمعاء. وبالتالي لا يبقى الطعام في نفس المكان لمدة طويلة. كما<br />يساعد على تصحيح حركة الطعام في المريء.<br />يمكن استعمال نوسيدوم لما يلي:<br />البالغون<br />&bull; لوقف أو منع الغثيان أو التقيؤ.<br />&bull; لوقف أو منع الشعور بالامتلاء أثناء أو بعد الطعام بقليل.<br />&bull; لعلاج الانزعاج المعدي، أو الشعور بالحرقة الناتج عن دخول محتويات المعدة إلى المريء<br />الأطفال<br />&bull; لوقف أو منع الغثيان أو التقيؤ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول نوسيدوم إذا:<br />&bull; كنت تتحسس (فرط حساسية) من الدومبيريدون أو أي من مكونات أقراص<br />نوسيدوم المغلفة الأخرى (المذكورة في فقرة ٦: محتويات العبوة ومعلومات أخرى).<br />تتضمن علامات ردود فعل الحساسية: طفح، انتفاخ أو مشاكل تنفسية، انتفاخ<br />الشفتين، الوجه، الحلق أو اللسان.<br />&bull; كنت تعاني من ورم في الغدة النخامية (ورم برولاكتيني).<br />&bull; كنت تعاني من انسداد أو تمزق في أمعائك.<br />&bull; كان برازك لونه أسود قطراني أو إذا لاحظت وجود دم في البراز. من الممكن أن يكون<br />هذا علامة للنزيف في المعدة أو الأمعاء.<br />&bull; كنت قد تعرضت سابقاً أو تعاني حالياً من مشاكل كبدية.<br />لا تتناول نوسيدوم إذا كان أي من المذكور في الأعلى ينطبق عليك. إن كنت ليس<br />متاكد، تواصل مع طبيبك او الصيدلي قبل تناول نوسيدوم.<br />محاذير خاصة عند استعمال نوسيدوم واسأل طبيبك أو الصيدلي قبل تناول هذا<br />الدواء إذا:<br />&bull; كنت تعاني من أي مشاكل كلوية. إن كنت تتناول نوسيدوم لفترة طويلة، من<br />الممكن أن يقلل طبيبك الكمية التي تستعملها. وهذا يعتمد على مدى شدة<br />المشاكل الكلوية التي تعاني منها.<br />إن كنت ليس متأكد ما إذا كان أي من المذكور في الأعلى ينطبق عليك، تواصل<br />مع طبيبك أو الصيدلي قبل تناول نوسيدوم. افعل هذا أيضاً إن كنت أصبت<br />سابقاً بما ذكر في الأعلى.<br />من الممكن أن يتعلق باستعمال نوسيدوم زيادة خطر اضطراب النظم القلبي وتوقف<br />القلب. قد يكون احتمال حدوث هذا الخطر أكثر لدى المرضى الأكبر من ٦٠ سنة من العمر<br />أو يتناولون جرعات أعلى من ٣٠ ملجم في اليوم. يجب استعمال نوسيدوم بأقل جرعة<br />فعالة لدى البالغين والأطفال.<br />نوسيدوم والأدوية الأخرى<br />من فضلك أخبر طبيبك أو الصيدلي إن كنت تتناول أو تناولت حديثاً أي أدوية أخرى بما<br />في ذلك الأدوية التي حصلت عليها بدون وصفة طبية كالأدوية العشبية. وذلك لأن<br />النوسيدوم قد يؤثر على طريقة عمل بعض الأدوية الأخرى. كما قد تؤثر بعض الأدوية<br />الأخرى على طريقة عمل النوسيدوم.<br />لا تستعمل نوسيدوم وأخبر طبيبك إن كنت تتناول أي مما يلي:<br />&bull; أقراص أو سائل الكيتوكونازول أو للعدوى الفطرية.<br />&bull; مضادات حيوية لعلاج العدوى (مثل إيريثرومايسين).<br />تناول نوسيدوم مع الطعام والشراب<br />يوصى بتناول النوسيدوم قبل الوجبات، حيث إنه عند تناوله بعد الوجبات يتأخر<br />امتصاصه قليلاً.<br />الحمل والإرضاع<br />أخبري طبيبك أو الصيدلي قبل تناول نوسيدوم إذا:<br />&bull; كنت حاملاً، قد تكونين حاملاً أو تعتقدين أنك حامل.<br />&bull; كنت مرضعة. من الأفضل عدم تناول نوسيدوم إن كنت مرضعة. وذلك لأن كمية<br />قليلة قد تعبر إلى حليب الأم.<br />القيادة واستعمال المكائن:<br />لا يؤثر النوسيدوم على قدرتك على القيادة أو استعمال المكائن.<br />معلومات مهمة عن بعض مكونات أقراص نوسيدوم<br />يحتوي هذا المنتج على لاكتوز. إن كان قد أخبرك طبيبك بأنك لا تستطيع هضم أو تحمل<br />بعض أنواع السكر، أخبر طبيبك قبل تناول نوسيدوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول دائما أقراص نوسيدوم كما أخبرك طبيبك تماماً. يجب عليك أن تتواصل مع طبيبك<br />أو الصيدلي إن كنت غير متأكد.<br />طريقة تناول هذا الدواء<br />&bull; ابتلع الأقراص كاملة مع شرب الماء.<br />&bull; تناول الأقراص قبل الوجبة ب ١٥ إلى ٣٠ دقيقة و، إن كان هناك حاجة، قبل النوم.<br />&bull; لا تحطم أو تمضغ الأقراص.<br />الجرعة الاعتيادية هي:<br />&bull; للبالغين والمراهقين (الأكبر من ١٢ سنة من العمر ويزنون أكثر من ٣٥ كجم): تناول<br />قرص أو قرصين ( ١٠ أو ٢٠ ملجم) من ٣ إلى ٤ مرات في اليوم.<br />لا تتناول أكثر من ٨ أقراص ( ٨٠ ملجم) في اليوم.<br />&bull; للأطفال<br />لا تعطي أقراص نوسيدوم للأطفال الأصغر من ١٢ سنة من العمر ويزنون أقل من ٣٥<br />كجم.<br />للأشخاص المصابين بمشاكل كلوية<br />قد يخبرك طبيبك أن تتناول أقل جرعة أو أحياناً قليلة.<br />ما هي مدة استعمال هذا الدواء؟<br />سوف يقرر طبيبك المدة التي تحتاجها لتناول هذا الدواء.<br />إن كنت ستتناول أقراص نوسيدوم لأكثر من أسبوعين، من الممكن أن<br />يطلب منك طبيبك زيارته مرة أخرى للتأكد من حاجتك للاستمرار في تناوله.<br />إذا تناولت نوسيدوم أكثر مما يجب:<br />&bull; إذا تناولت أقراص نوسيدوم أكثر مما يجب، تواصل مع الطبيب أو اذهب إلى أقرب<br />مستشفى فوراً. اصطحب العبوة أو أي أقراص متبقية معك لكي يستطيع<br />الأطباء معرفة ما تناولته.<br />&bull; علامات التناول المفرط هي الشعور بالنعاس، الارتباك، حركات غير مسيطر عليها<br />(خصوصاً عند الأطفال) والتي تتضمن حركات عينية غير معتادة، حركات غير<br />معتادة للسان أو وضعية غير طبيعية (مثل الرقبة الملتوية).<br />إذا نسيت تناول نوسيدوم:<br />&bull; إذا نسيت تناول جرعة نوسيدوم، تناولها بمجرد ما تتذكرها.<br />&bull; مع ذلك إن كان وقت تذكر الجرعة هو نفس وقت الجرعة التالية، تجاوز أخذ الجرعة<br />التي نسيتها.&nbsp;لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال في كل الأدوية، من الممكن أن يسبب النوسيدوم آثار جانبية، على الرغم<br />من أنها لا تحدث عند كل شخص.<br />توقف عن استعمال النوسيدوم وتواصل مع طبيبك أو اذهب إلى المستشفى فوراً إذا:<br />&bull; تورمت يداك، قدماك، كاحلاك، وجهك، شفتاك أو حلقك ما قد يسبب صعوبة<br />في البلع أو التنفس. كما من الممكن أن تلاحظ حدوث طفح متكتل مع حكة<br />(شرى) أو طفح القراص (أرتيكاريا) مما قد يشير إلى إصابتك بردود فعل<br />حساسية من جراء استعمال النوسيدوم.<br />&bull; لا حظت حدوث أي حركات غير مسيطر عليها. وهذا يضم حركات العين غير<br />المنتظمة، حركات اللسان غير المعتادة، ووضعيات غير طبيعية مثل الرقبة<br />الملتوية، الارتعاش وتيبس العضل. احتمال حدوثها أكثر في حالة الأطفال. من<br />المفترض أن تتوقف هذه الأعراض بمجرد وقف استعمال النوسيدوم.<br />&bull; كان لديك ضربات قلبية سريعة جداً أو غير معتادة. ومن الممكن أن تكون هذه<br />علامات مشكلة قلبية مهددة للحياة.<br />&bull; كنت تتعرض لتشنجات (نوبات صرع).</p><p>آثار جانبية أخرى:<br />شائعة (تؤثر على أقل من ١ شخص من ضمن ١٠ أشخاص)<br />&bull; جفاف الفم<br />غير شائعة (تؤثر على أقل من ١ شخص من ضمن ١٠٠ شخص)<br />&bull; نقص النشاط الجنسي لدى الرجال<br />&bull; الشعور بالقلق<br />&bull; الشعور بالدوار<br />&bull; صداع<br />&bull; حكة جلدية. وقد تصاب أيضاً بطفح<br />&bull; إنتاج غير طبيعي في حليب الصدر لدى الرجال والنساء<br />&bull; ألم في الثديين ولينهما<br />&bull; الشعور العام بالضعف<br />آثار جانبية لا يمكن تقدير تكرارها من المعلومات المتاحة<br />&bull; الشعور بتوتر وتهيج<br />&bull; الشعور بعصبية غير طبيعية<br />&bull; تحركات للعين غير طبيعية<br />&bull; صعوبة التبول<br />&bull; تضخم الثديين لدى الرجال<br />&bull; لدى النساء، اضطراب الدورة الشهرية أو توقفها<br />&bull; ظهور تغيرات في الفحوصات الدموية فيما يتعلق بالوظيفة الكبدية<br />تعرض بعض المرضى الذين استعملوا النوسيدوم لظروف وجرعات تحتاج إلى رقابة طبية<br />طويلة الأمد إلى الآثار غير المرغوبة التالية:<br />التململ؛ تورم أو تضخم الثديين، تخريج غير طبيعي من الثديين، دورة شهرية غير<br />منتظمة لدى النساء، صعوبة الإرضاع، اكتئاب، فرط حساسية.<br />من الممكن أن يصاحب استعمال النوسيدوم زيادة في خطر اضطراب النظم القلبي<br />وتوقف القلب. احتمال حدوث هذا الخطر أكثر لدى المرضى الأكبر من ٦٠ سنة من العمر<br />أو يتناولون جرعات أعلى من ٣٠ ملجم في اليوم. يجب استعمال نوسيدوم بأقل جرعة<br />فعالة لدى البالغين والأطفال.<br />الآثار الجانبية مثل الشعور بنعاس، عصبية، اضطراب أو غضب أو حدوث تشنج أكثر<br />حدوثاً في الأطفال.<br />إذا زادت حدة الآثار الجانبية أو استمرت لأكثر من عدة أيام، أو لاحظت ظهور أي آثار جانبية<br />غير مذكورة في هذه النشرة، من فضلك أخبر طبيبك أو الصيدلي.<br />للإبلاغ عن الأعراض الجانبية:<br />&bull; المملكة العربية السعودية:</p><p>&bull; دول الخليج الأخرى:<br />الرجاء الإتصال بالمؤسسات والهيئات الوطنية لكل دولة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; يحفظ بعيداً عن متناول الأطفال.<br />&bull; يحفظ عند درجة حرارة أقل من ٣٠ &deg;م.<br />&bull; لا تتناول أقراص نوسيدوم بعد تاريخ الانتهاء المذكور على العبوة.<br />&bull; اسأل الصيدلي عن كيفية التخلص من الأدوية التي ليس بحاجة إليها. يجب عدم<br />التخلص من الأدوية عن طريق إلقائها في المرحاض أو حوض الغسيل أو النفايات<br />المنزلية. هذه المقاييس سوف تساعد لحماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>٦. محتويات العبوة ومعلومات أخرى<br />ماذا تحتوي أقراص نوسيدوم المغلفة<br />كل قرص نوسيدوم يحتوي على ١٠ ملجم دومبيريدون (المادة الفعالة). كما يحتوي على<br />لاكتوز، نشا الذرة، صوديوم لوريل سلفات، سليولوز دقيق البلورة، بوفيدون، ستيرات<br />٧٠٠٠ وماء نقي. - الماغنيسيوم، سيليكا غروانية لامائية، أوبادراي أبيض واي- ١<br />كيف تبدو أقراص نوسيدوم ١٠ ملجم المغلفة ومحتويات العبوة<br />٣ أشرطة) قرص كل منها مغلف أبيض اللون إلى x ١٠ أقراص ) كل عبوة تحتوي على ٣٠<br />من جانب و&quot; ١٠ &quot; من الجانب &quot;n&quot; أبيض مائل إلى الصفرة دائري الشكل محفور عليه<br />الآخر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>٦. محتويات العبوة ومعلومات أخرى<br />ماذا تحتوي أقراص نوسيدوم المغلفة<br />كل قرص نوسيدوم يحتوي على ١٠ ملجم دومبيريدون (المادة الفعالة). كما يحتوي على<br />لاكتوز، نشا الذرة، صوديوم لوريل سلفات، سليولوز دقيق البلورة، بوفيدون، ستيرات<br />٧٠٠٠ وماء نقي. - الماغنيسيوم، سيليكا غروانية لامائية، أوبادراي أبيض واي- ١<br />كيف تبدو أقراص نوسيدوم ١٠ ملجم المغلفة ومحتويات العبوة<br />٣ أشرطة) قرص كل منها مغلف أبيض اللون إلى x ١٠ أقراص ) كل عبوة تحتوي على ٣٠<br />من جانب و&quot; ١٠ &quot; من الجانب &quot;n&quot; أبيض مائل إلى الصفرة دائري الشكل محفور عليه<br />الآخر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>نيوفارما&nbsp;</p><p>٥ ، مدينة أبوظبي -٨٩ قطعة رقم إيه- ١<br />الصناعية، مصفح، ص.ب. ٧٢٩٠٠ ، أبوظبي، إ.ع.م.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Nausidom Tablets 10 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains Domperidone 10 mg.
‘For full list of excipients, see section 6.1’.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone Tablets 10 mg is indicated for relief of the symptoms of nausea and<br />vomiting.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nausidom tablets 10 mg should be used at the lowest effective dose for the<br />shortest duration necessary to control nausea and vomiting.<br />It is recommended to take oral Domperidone Tablets 10 mg before meals. If<br />taken after meals, absorption of the drug is somewhat delayed.<br />Patients should try to take each dose at the scheduled time. If a scheduled dose<br />is missed, the missed dose should be omitted and the usual dosing schedule<br />resumed. The dose should not be doubled to make up for a missed dose.<br />Usually, the maximum treatment duration should not exceed one week.<br />Adults and adolescents (12 years of age and older and weighing 35 kg or<br />more)<br />One 10mg tablet up to three times per day with a maximum dose of 30 mg per<br />day.<br />Neonates, infants, children (less than 12 years of age) and adolescents weighing<br />less than 35 kg.</p><p>Due to the need for accurate dosing, Domperidone Tablets 10 mg are unsuitable<br />for use in children and adolescents weighing less than 35 kg.<br />Hepatic Impairment<br />Domperidone Tablets 10 mg is contraindicated in moderate or severe hepatic<br />impairment. Dose modification in mild hepatic impairment is however not needed.<br />Renal Impairment<br />Since the elimination half-life of domperidone is prolonged in severe renal<br />impairment, on repeated administration, the dosing frequency of Domperidone<br />Tablets 10 mg should be reduced to once or twice daily depending on the severity<br />of the impairment, and the dose may need to be reduced. Such patients on<br />prolonged therapy should be reviewed regularly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Domperidone Tablets 10 mg is contraindicated in the following situations:
• Known hypersensitivity to domperidone or any of the excipients
• Prolactin-releasing pituitary tumour (prolactinoma).
• when stimulation of the gastric motility could be harmful e.g in patients with
gastro-intestinal haemorrhage, mechanical obstruction or perforation.
• in patients with moderate or severe hepatic impairment.
• in patients who have known existing prolongation of cardiac conduction
intervals, particularly QTc, patients with significant electrolyte disturbances or
underlying cardiac diseases such as congestive heart failure.
• co-administration with QT-prolonging drugs.
• co-administration with potent CYP3A4 inhibitors (regardless of their QT
prolonging effects)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cardiovascular effects<br />Domperidone has been associated with prolongation of the QT interval on the<br />electrocardiogram. During post-marketing surveillance, there have been very rare&nbsp;cases of QT prolongation and torsades de pointes in patients taking domperidone.<br />These reports included patients with confounding risk factors, electrolyte<br />abnormalities and concomitant treatment which may have been contributing<br />factors.<br />Epidemiological studies showed that domperidone was associated with an<br />increased risk of serious ventricular arrhythmias or sudden cardiac death. A<br />higher risk was observed in patients older than 60 years, patients taking daily<br />doses greater than 30 mg, and patients concurrently taking QT-prolonging drugs<br />or CYP3A4 inhibitors.<br />Domperidone should be used at the lowest effective dose in adults and children.<br />Domperidone is contraindicated in patients with known existing prolongation of<br />cardiac conduction intervals, particularly QTc, in patients with significant<br />electrolyte disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia), or<br />bradycardia, or in patients with underlying cardiac diseases such as congestive<br />heart failure due to increased risk of ventricular arrhythmia. Electrolyte<br />disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia) or bradycardia<br />are known to be conditions increasing the proarrythmic risk.<br />Treatment with domperidone should be stopped if signs or symptoms occur that<br />may be associated with cardiac arrhythmia, and the patients should consult their<br />physician.<br />Patients should be advised to promptly report any cardiac symptoms.<br />Use in infants<br />Although neurological side effects are rare, the risk of neurological side effects is<br />higher in young children since metabolic functions and the blood-brain barrier are<br />not fully developed in the first months of life. Overdosing may cause<br />extrapyramidal symptoms in children, but other causes should be taken into<br />consideration.<br />Renal impairment<br />The elimination half-life of domperidone is prolonged in severe renal impairment.<br />For repeated administration, the dosing frequency of Domperidone Tablets 10 mg<br />should be reduced to once or twice daily depending on the severity of the<br />impairment. The dose may also need to be reduced.</p><p>Excipients<br />The film-coated tablets contain lactose. Patients with rare hereditary problems of<br />galactose intolerance, the Lapp lactase deficiency or glucose-galactose<br />malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The main metabolic pathway of domperidone is through CYP3A4. In vitro data<br />suggest that the concomitant use of drugs that significantly inhibit this enzyme<br />may result in increased plasma levels of domperidone.<br />Increased risk of occurrence of QT-interval prolongation, due to<br />pharmacodynamic and/or pharmacokinetic interactions.<br />Concomitant use of the following substances is contraindicated<br />QTc prolonging medicinal products<br />&bull; anti-arrhythmics class IA (e.g., disopyramide, hydroquinidine, quinidine)<br />&bull; anti-arrhythmics class III (e.g., amiodarone, dofetilide, dronedarone, ibutilide,<br />sotalol)<br />&bull; certain anti-psychotics (e.g., haloperidol, pimozide, sertindole)<br />&bull; certain anti-depressants (e.g., citalopram, escitalopram)<br />&bull; certain antibiotics (e.g. , erythromycin, levofloxacin, moxifloxacin, spiramycin)<br />&bull; certain antifungal agents (e.g., pentamidine)<br />&bull; certain antimalarial agents (in particular halofantrine, lumefantrine)<br />&bull; certain gastro-intestinal medicines (e.g., cisapride, dolasetron, prucalopride)<br />&bull; certain antihistaminics (e.g., mequitazine, mizolastine)<br />&bull; certain medicines used in cancer (e.g., toremifene, vandetanib, vincamine)<br />&bull; certain other medicines (e.g., bepridil, diphemanil, methadone).<br />&bull; Potent CYP3A4 inhibitors (regardless of their QT prolonging effects), i.e.:<br />&bull; protease inhibitors<br />&bull; systemic azole antifungals<br />&bull; some macrolides (erythromycin, clarithromycin, telithromycin)<br />Concomitant use of the following substances is not recommended<br />Moderate CYP3A4 inhibitors i.e. diltiazem, verapamil and some macrolides.</p><p>Concomitant use of the following substances requires caution in use<br />Caution with bradycardia and hypokalaemia-inducing drugs, as well as with the<br />following macrolides involved in QT-interval prolongation: azithromycin and<br />roxithromycin (clarithromycin is contra-indicated as it is a potent CYP3A4<br />inhibitor).<br />The above list of substances is representative and not exhaustive.<br />Separate in vivo pharmacokinetic/pharmacodynamic interaction studies with oral<br />ketoconazole or oral erythromycin in healthy subjects confirmed a marked<br />inhibition of domperidone&#39;s CYP3A4 mediated first pass metabolism by these<br />drugs.<br />With the combination of oral domperidone 10mg four times daily and<br />ketoconazole 200mg twice daily, a mean QTc prolongation of 9.8 msec was seen<br />over the observation period, with changes at individual time points ranging from<br />1.2 to 17.5 msec. With the combination of domperidone 10mg four times daily<br />and oral erythromycin 500mg three times daily, mean QTc over the observation<br />period was prolonged by 9.9 msec, with changes at individual time points ranging<br />from 1.6 to 14.3 msec. Both the Cmax and AUC of domperidone at steady state<br />were increased approximately three-fold in each of these interaction studies. In<br />these studies domperidone monotherapy at 10mg given orally four times daily<br />resulted in increases in mean QTc of 1.6msec (ketoconazole study) and 2.5msec<br />(erythromycin study), while ketoconazole monotherapy (200mg twice daily) led<br />to increases in QTc of 3.8 and 4.9 msec, respectively, over the observation<br />period.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are limited post-marketing data on the use of domperidone in pregnant<br />women. Studies in animals have shown reproductive toxicity at maternally toxic<br />doses. Domperidone Tablets 10 mg should only be used during pregnancy when<br />justified by the anticipated therapeutic benefit.</p><p>Breast-feeding<br />Domperidone is excreted in human milk and breast-fed infants receive less than<br />0.1 % of the maternal weight-adjusted dose. Occurrence of adverse effects, in<br />particular cardiac effects cannot be excluded after exposure via breast milk. A<br />decision should be made whether to discontinue breast-feeding or to<br />discontinue/abstain from domperidone therapy taking into account the benefit of<br />breast feeding for the child and the benefit of therapy for the woman. Caution<br />should be exercised in case of QTc prolongation risk factors in breast-fed infants.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone Tablets 10 mg has no or negligible influence on the ability to drive<br />and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tabulated list of adverse reactions<br />The safety of Domperidone Tablets 10 mg was evaluated in clinical trials and in<br />postmarketing experience. The clinical trials included 1275 patients with<br />dyspepsia, gastro-oesophageal reflux disorder (GORD), Irritable Bowel Syndrome<br />(IBS), nausea and vomiting or other related conditions in 31 double-blind,<br />placebo-controlled studies. All patients were at least 15 years old and received at<br />least one dose of Domperidone Tablets 10 mg (domperidone base). The median<br />total daily dose was 30 mg (range 10 to 80 mg), and median duration of<br />exposure was 28 days (range 1 to 28 days). Studies in diabetic gastroparesis or<br />symptoms secondary to chemotherapy or parkinsonism were excluded.<br />The following terms and frequencies are applied:<br />very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to<br />&lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), Where<br />frequency can not be estimated from clinical trials data, it is recorded as &ldquo;Not<br />known&rdquo;.</p><p>SYSTEM ORGAN<br />CLASS<br />ADVERSE DRUG REACTION FREQUENCY<br />COMMON UNCOMMON NOT KNOWN<br />Immune system<br />disorders<br />Anaphylactic reaction<br />(including<br />anaphylactic shock)<br />Psychiatric disorders Loss of libido<br />Anxiety<br />Agitation<br />Nervousness<br />Nervous system<br />disorders<br />Somnolence<br />Headache<br />Convulsion<br />Extrapyramidal<br />disorder<br />Eye disorders Oculogyric crisis<br />Cardiac disorders Ventricular<br />arrhythmias<br />Sudden cardiac death<br />QTc prolongation<br />Torsade de Pointes<br />Gastrointestinal<br />disorders<br />Dry mouth Diarrhoea<br />Skin and<br />subcutaneous tissue<br />disorder<br />Rash<br />Pruritus<br />Urticaria<br />Angioedema<br />Renal and urinary<br />disorders<br />Urinary retention<br />Reproductive system<br />and breast disorders<br />Galactorrhoea<br />Breast pain<br />Breast tenderness<br />Gynaecomastia<br />Amenorrhoea<br />General disorders and<br />administration site<br />conditions<br />Asthenia<br />Investigations Liver function test<br />abnormal<br />Blood prolactin<br />increased.</p><p>In 45 studies where domperidone was used at higher dosages, for longer duration and for<br />additional indications including diabetic gastroparesis, the frequency of adverse events (apart<br />from dry mouth) was considerably higher. This was particularly evident for pharmacologically<br />predictable events related to increased prolactin. In addition to the reactions listed above,<br />akathisia, breast discharge, breast enlargement, breast swelling, depression,<br />hypersensitivity, lactation disorder, and irregular menstruation were also noted.</p><p>Paediatric population<br />Extrapyramidal disorder occurs primarily in neonates and infants<br />Other central nervous system-related effects of convulsion and agitation also are<br />primarily reported in infants and children.<br />To report any side effect(s):<br /> Saudi Arabia:<br /> The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br /> Other GCCStates:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />Overdose has been reported primarily in infants and children. Symptoms of<br />overdosage may include agitation, altered consciousness,<br />convulsions,disorientation, somnolence and extrapyramidal reactions.<br />Treatment<br />There is no specific antidote to domperidone, but in the event of overdose,<br />standard symptomatic treatment should be given immediately. Gastric lavage as<br />well as the administration of activated charcoal, may be useful. ECG monitoring<br />should be undertaken, because of the possibility of QT interval prolongation.<br />Close medical supervision and supportive therapy is recommended.<br />Anticholinergic, anti-parkinson drugs may be helpful in controlling the<br />extrapyramidal reactions.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5. PHARMACOLOGICAL PROPERTIES<br />5.1 Pharmacodynamic Properties<br />Pharmacotherapeutic Group : Propulsives<br />ATC Code: A03FA03<br />Mechanism of action<br />Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone<br />does not readily cross the blood-brain barrier. In domperidone users, especially in<br />adults, extrapyramidal side effects are very rare, but domperidone promotes the<br />release of prolactin from the pituitary. Its anti-emetic effect may be due to a<br />combination of peripheral (gastrokinetic) effects and antagonism of dopamine<br />receptors in the chemoreceptor trigger zone, which lies outside the blood-brain<br />barrier in the area postrema. Animal studies, together with the low<br />concentrations found in the brain, indicate a predominantly peripheral effect of<br />domperidone on dopamine receptors.<br />Studies in man have shown oral domperidone to increase lower oesophaegeal<br />pressure, improve antroduodenal motility and accelerate gastric emptying. There<br />is no effect on gastric secretion.<br />In accordance with ICH&mdash;E14 guidelines, a thorough QT study was performed.<br />This study included a placebo, an active comparator and a positive control and<br />was conducted in healthy subjects with up to 80 mg per day 10 or 20 mg<br />administered 4 times a day of domperidone. This study found a maximal<br />difference of QTc between domperidone and placebo in LS-means in the change<br />from baseline of 3.4 msec for 20 mg domperidone administered 4 times a day on<br />Day 4. The 2-sided 90 % CI (1.0 to 5.9 msec) did not exceed 10 msec. No<br />clinically relevant QTc effects were observed in this study when domperidone was<br />administered at up to 80 mg/day (i.e., more than twice the maximum<br />recommended dosing).<br />However, two previous drug-drug interaction studies showed some evidence of<br />QTc prolongation when domperidone was administered as monotherapy (10 mg 4<br />times a day).The largest time-matched mean difference of QTcF between<br />domperidone and placebo was 5.4 msec (95 % CI: -1.7 to 12.4) and 7.5 msec<br />(95 % CI: 0.6 to 14.4), respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Domperidone is rapidly absorbed after oral administration, with peak plasma<br />concentrations occurring at approximately 1hr after dosing. The Cmax and AUC<br />values of domperidone increased proportionally with dose in the 10 mg to 20 mg<br />dose range. A 2- to 3-fold accumulation of domperidone AUC was observed with<br />repeated four times daily (every 5 hr) dosing of domperidone for 4 days.<br />The low absolute bioavailability of oral domperidone (approximately 15%) is due<br />to an extensive first-pass metabolism in the gut wall and liver. Although<br />domperidone&#39;s bioavailability is enhanced in normal subjects when taken after a<br />meal, patients with gastro-intestinal complaints should take domperidone 15-30<br />minutes before a meal. Reduced gastric acidity impairs the absorption of<br />domperidone.<br />Oral bioavailability is decreased by prior concomitant administration of cimetidine<br />and sodium bicarbonate. The time of peak absorption is slightly delayed and the<br />AUC somewhat increased when the oral drug is taken after a meal.<br />Distribution<br />Oral domperidone does not appear to accumulate or induce its own metabolism;<br />a peak plasma level after 90 minutes of 21 ng/ml after two weeks oral<br />administration of 30 mg per day was almost the same as that of 18 ng/ml after<br />the first dose. Domperidone is 91-93% bound to plasma proteins. Distribution<br />studies with radiolabelled drug in animals have shown wide tissue distribution,<br />but low brain concentration. Small amounts of drug cross the placenta in rats.<br />Metabolism<br />Domperidone undergoes rapid and extensive hepatic metabolism by<br />hydroxylation and N-dealkylation. In vitro metabolism experiments with<br />diagnostic inhibitors revealed that CYP3A4 is a major form of cytochrome P-450<br />involved in the N-dealkylation of domperidone, whereas CYP3A4, CYP1A2 and<br />CYP2E1 are involved in domperidone aromatic hydroxylation.<br />Excretion<br />Urinary and faecal excretions amount to 31 and 66% of the oral dose<br />respectively. The proportion of the drug excreted unchanged is small (10% of<br />faecal excretion and approximately 1% of urinary excretion). The plasma half-life&nbsp;after a single oral dose is 7-9 hours in healthy subjects but is prolonged in<br />patients with severe renal insufficiency.<br />Hepatic impairment<br />In subjects with moderate hepatic impairment (Pugh score 7 to 9, Child-Pugh<br />rating B), the AUC and Cmax of domperidone is 2.9- and 1.5-fold higher,<br />respectively, than in healthy subjects. The unbound fraction is increased by 25%,<br />and the terminal elimination half-life is prolonged from 15 to 23 hours. Subjects<br />with mild hepatic impairment have a somewhat lower systemic exposure than<br />healthy subjects based on Cmax and AUC, with no change in protein binding or<br />terminal half-life. Subjects with severe hepatic impairment were not studied.<br />Domperidone Tablets 10 mg is contraindicated in patients with moderate or<br />severe hepatic impairment.<br />Renal impairment<br />In subjects with severe renal insufficiency (creatinine clearance<br />&lt;30ml/min/1.73m2) the elimination half-life of domperidone is increased from 7.4<br />to 20.8 hours, but plasma drug levels are lower than in healthy volunteers. Since<br />very little unchanged drug (approximately 1%) is excreted via the kidneys, it is<br />unlikely that the dose of a single administration needs to be adjusted in patients<br />with renal insufficiency.<br />However, on repeated administration, the dosing frequency should be reduced to<br />once or twice daily depending on the severity of the impairment, and the dose<br />may need to be reduced.<br />Paediatric population<br />No pharmacokinetic data are available in the paediatric population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Electrophysiological in vitro and in vivo studies indicate an overall moderate risk<br />of domperidone to prolong the QT interval in humans. In in vitro experiments on<br />isolated cells transfected with hERG and on isolated guinea pig myocytes,<br />exposure ratios ranged between 26- 47-fold, based on IC50 values inhibiting<br />currents through IKr ion channels in comparison to the free plasma<br />concentrations in humans after administration of the maximum daily dose of 10<br />mg administered 3 times a day. Safety margins for prolongation of action<br />potential duration in in vitro experiments on isolated cardiac tissues exceeded the&nbsp;free plasma concentrations in humans at maximum daily dose (10 mg<br />administered 3 times a day) by 45-fold. Safety margins in in vitro pro-arrhythmic<br />models (isolated Langendorff perfused heart) exceeded the free plasma<br />concentrations in humans at maximum daily dose (10 mg administered 3 times a<br />day) by 9- up to 45-fold. In in vivo models the no effect levels for QTc<br />prolongation in dogs and induction of arrhythmias in a rabbit model sensitized for<br />torsade de pointes exceeded the free plasma concentrations in humans at<br />maximum daily dose (10 mg administered 3 times a day) by more than 22-fold<br />and 435-fold, respectively. In the anesthetized guinea pig model following slow<br />intravenous infusions, there were no effects on QTc at total plasma<br />concentrations of 45.4 ng/mL, which are 3-fold higher than the total plasma<br />levels in humans at maximum daily dose (10 mg administered 3 times a day).<br />The relevance of the latter study for humans following exposure to orally<br />administered domperidone is uncertain.<br />In the presence of inhibition of the metabolism via CYP3A4 free plasma<br />concentrations of domperidone can rise up to 3-fold.<br />At a high, maternally toxic dose (more than 40 times the recommended human<br />dose), teratogenic effects were seen in the rat. No teratogenicity was observed in<br />mice and rabbits.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>S. NO. MATERIAL FUNCTION<br />CORE EXCIPIENTS<br />1. Lactose (200 mesh)Ph.Eur. Diluent<br />2. Maize Starch Ph.Eur. Diluent<br />3. Sodium Lauryl Sulphate BP Surfactant<br />4. Povidone (K-29/32) BP Binder<br />5. Purified Water USP Granulating Agent<br />6. Microcrystalline Cellulose (Grade 102)<br />BP/Ph.Eur.<br />Diluent<br />7. Colloidal Anhydrous Silica BP/Ph.Eur. Glidant<br />8. Magnesium Stearate Ph.Eur. Lubricant<br />9. Opadry White Y-1-7000 Coating Agent<br />PRODUCT NAUSIDOM TABLETS 10 mg<br />REGISTRATION FILE &ndash; MODULE 1</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The tablets are packed in Alu/PVC-PVDC blisters and placed in a printed carton<br />along with the pack insert.<br />Pack size: 30&rsquo;s.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                6.6 Manufacturer
Neopharma
Plot No. 89A1-95A1,
Industrial City of Abu Dhabi, Mussafah,
PO Box 72900
Abu Dhabi, UAE
6.7 Marketing Authorization Holder
Neopharma
Plot No. 89A1-95A1,
Industrial City of Abu Dhabi, Mussafah,
PO Box 72900
Abu Dhabi, UAE
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                16th Feb 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>